slieder03 THERAPY OF ARTERIOSCLEROSIS
IS PREPARED FOR APPROVAL
The developement of a specialized drug for our
therapy has been realized with genetic technologies.
slieder01 BEST DESCRIBES US AS A
THINK TANK COMPANY.
At Pharmact, our mission is to improve
the health of those we serve.
slieder01 CROSS-THINKING IS OUR ROUTE
TO NEW HEALTH SOLUTIONS.
Our scientists enjoy being innovative.
It´s their goal realizing medical tools.

Pharmact

OUR MISSION

At Pharmact, our mission is to improve the health of those we serve. We have focused on the most important clinical pictures, arteriosclerosis and diabetes.
.

More...

Pharmact

INTERNATIONAL

We work worldwide with pharmaceutical wholeseller and distributions. We are pleased if you would like being part of our network.
.

More...

Pharmact

MEDICAL DEVICES

Our IVD rapid test products are excellent for the screening of metabolic diseases and risk diagnosis. Take advantage of our Smart Devices.
.

More...

NEWS PRODUCTS

Rapid test Corona virus:

The SARS-CoV infection is recognized by the immunoglobulins IgM and IgG in the blood of patients. When cross-matched with the PCR smear test, our test shows 99,8% correlation in the detection of non-infected persons.

By 20 June 2020, a cumulative amount of 1,809 tests had been carried out for validation. Of those, 643 measurements were evaluated to determine test sensitivity and 1,166 to determine specificity.The Point-of-Care test may be ordered by healthcare professionals and pharmacies  only. More…

Screening for metabolic diseases on early stages

The effective therapy of diabetes mellitus and arteriosclerosis as well as their sequelae is one of the greatest medical challenges of our time. More…

NEW PROJECTS

New substance in registration process

Arteriosclerosis is a silent disease that partially leads to calcifying hardening of the arterial system. Pharmact has developed a specific drug that is available from the beginning of Q2. 2020. The substance has now been entered the drug approval process.

locations

DISTRIBUTION

Pharmact GmbH
International Distribution Headquarters
Phone:    +49 (0) 621-1806178-0
Fax:         +49 (0) 621-1806178-9
Contact:  sales@pharmact.de

Pharmact Healthcare Inc.
Distribution USA / CAN
Contact:   sales@pharmact-us.com
Phone  +1 813 200 5884

PARTNER

BBL Healthcare Solutions Ltd.
Phone:   +44 7848 844 048
Contact:  info@bblhealthcaresolutions.com